Skip to main content
TARS logo

TARS · Tarsus Pharmaceuticals, Inc. · Documents

Track TARS — free
$78.20 -0.48 (-0.61%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$3.86B
Shares
49.31M
Volume · Nov 17 542.25K Avg daily vol (3M) 874.8K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Feb 25
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $182.95M ▲ 948.6% Net loss $115.55M Diluted EPS -$3.07
2024
Feb 27
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $17.45M ▼ 32.4% Net loss $135.89M Diluted EPS -$4.62
2023
Mar 17
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $25.82M ▼ 54.7% Net loss $62.09M Diluted EPS -$2.52
2022
Showing 51–100 of 141 documents
Key facts CIK 1819790 CUSIP 87650L103 13F (30d) 263 filings 247 filers Visit website Investor relations